Search Count: 9
 |
Crystal Structure Of The Catalytic Domain Of Adamts-5 In Complex With The Inhibitor Glpg1972
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.25 Å Release Date: 2021-04-14 Classification: HYDROLASE Ligands: ZN, CA, OU5 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2021-04-14
Ligands: ZN, CA, OU5
 |
Novel Imidazo[1,2-A]Pyridine Derivatives With Potent Autotaxin/Enpp2 Inhibitor Activity
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.70 Å Release Date: 2017-08-30 Classification: HYDROLASE Ligands: 7HR, IOD, CL, SCN, NI, PO4, K, ZN |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2017-08-30
Ligands: 7HR, IOD, CL, SCN, NI, PO4, K, ZN
 |
Novel Imidazo[1,2-A]Pyridine Derivatives With Potent Autotaxin/Enpp2 Inhibitor Activity
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.43 Å Release Date: 2017-08-30 Classification: HYDROLASE Ligands: NAG, ZN, CA, MG, IOD, CL, SCN, PO4, 7NB |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2017-08-30
Ligands: NAG, ZN, CA, MG, IOD, CL, SCN, PO4, 7NB
 |
Triazolopyridine Compounds As Selective Jak1 Inhibitors: From Hit Identification To Glpg0634
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.40 Å Release Date: 2014-11-19 Classification: TRANSFERASE Ligands: 2HB |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2014-11-19
Ligands: 2HB
 |
Novel N-Phenyl-Phenoxyacetamide Derivatives As Potential Ethr Inhibitors And Ethionamide Boosters. Discovery And Optimization Using High-Throughput Synthesis.
Organism: Mycobacterium tuberculosis
Method: X-RAY DIFFRACTION Resolution:2.00 Å Release Date: 2013-03-27 Classification: TRANSCRIPTION/INHIBITOR Ligands: 0MN, NH4, GOL |
Organism: Mycobacterium tuberculosis
Method: X-RAY DIFFRACTION
Release Date: 2013-03-27
Ligands: 0MN, NH4, GOL
 |
Ethr From Mycobacterium Tuberculosis In Complex With Compound Bdm31379
Organism: Mycobacterium tuberculosis
Method: X-RAY DIFFRACTION Resolution:1.70 Å Release Date: 2012-01-11 Classification: TRANSCRIPTION/TRANSCRIPTION INHIBITOR Ligands: LL3 |
Organism: Mycobacterium tuberculosis
Method: X-RAY DIFFRACTION
Release Date: 2012-01-11
Ligands: LL3
 |
Ethr From Mycobacterium Tuberculosis In Complex With Compound Bdm31369
Organism: Mycobacterium tuberculosis
Method: X-RAY DIFFRACTION Resolution:1.95 Å Release Date: 2012-01-11 Classification: TRANSCRIPTION/TRANSCRIPTION INHIBITOR Ligands: LL4 |
Organism: Mycobacterium tuberculosis
Method: X-RAY DIFFRACTION
Release Date: 2012-01-11
Ligands: LL4
 |
Ethionamide Boosters Part 2: Combining Bioisosteric Replacement And Structure-Based Drug Design To Solve Pharmacokinetic Issues In A Series Of Potent 1,2,4-Oxadiazole Ethr Inhibitors.
Organism: Mycobacterium tuberculosis
Method: X-RAY DIFFRACTION Resolution:1.87 Å Release Date: 2011-12-07 Classification: TRANSCRIPTION REPRESSOR/INHIBITOR Ligands: 3SE |
Organism: Mycobacterium tuberculosis
Method: X-RAY DIFFRACTION
Release Date: 2011-12-07
Ligands: 3SE
 |
Ethionamide Boosters Part 2: Combining Bioisosteric Replacement And Structure-Based Drug Design To Solve Pharmacokinetic Issues In A Series Of Potent 1,2,4-Oxadiazole Ethr Inhibitors.
Organism: Mycobacterium tuberculosis
Method: X-RAY DIFFRACTION Resolution:2.31 Å Release Date: 2011-12-07 Classification: TRANSCRIPTION REPRESSOR/INHIBITOR Ligands: 3SF |
Organism: Mycobacterium tuberculosis
Method: X-RAY DIFFRACTION
Release Date: 2011-12-07
Ligands: 3SF